Pulmonary Disease

News Pulmonary Disease

• Allergic disease worsens respiratory symptoms and exacerbations in COPD

  Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore. "Although allergic sensitization and more

• Tobacco constituent extraction from snus during consumer use

  Scientists at British American Tobacco have used a multi-analyte approach to determine the level of exposure to tobacco constituents of snus users. The results show that, generally, less than a third of each constituent measured was extracted by consumers during use. Snus is a moist snuff that is pl more

• Marine compound discovery shows promise of improved drug treatment for COPD patients

  Pharmacy researchers at the University of Florida have isolated a new marine compound they believe may lead to improved drug therapies for pulmonary diseases by inhibiting their progression rather than managing their symptoms. Known as symplostatin 5, the compound was extracted from blue-green algae more

Publications Pulmonary Disease

• Inhibitory effects of hesperetin derivatives on guinea pig phosphodiesterases and Their ratios between high‐ and low‐affinity rolipram binding

  Abstract The phosphodiesterase (PDE)4 molecule exists as two distinct conformers, PDE4H and PDE4L, which have high and low affinities, respectively, for the selective PDE4 inhibitor, rolipram. The inhibition of PDE4H and PDE4L is associated with adverse responses, such as nausea, vomiting, and g more

• The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population

  by Roberto de Marco, Giancarlo Pesce, Alessandro Marcon, Simone Accordini, Leonardo Antonicelli, Massimiliano Bugiani, Lucio Casali, Marcello Ferrari, Gabriele Nicolini, Maria Grazia Panico, Pietro Pirina, Maria Elisabetta Zanolin, Isa Cerveri, Giuseppe Verlato Background The joint distribution o more

• Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease

  Panos RJ more

Market studies Pulmonary Disease

• Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012" provides data on the Obstructive Pulmonary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Obstructive Pu more

• Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pu more

• Anesthesia and Respiratory Devices Market to 2017 - Sleep Apnea Diagnostic Systems and Portable Anesthesia Delivery Machines to be the Fastest Growing Categories

  GBI Research’s report, “Anesthesia and Respiratory Devices Market to 2017 - Sleep Apnea Diagnostic Systems and Portable Anesthesia Delivery Machines to be the Fastest Growing Categories” provides key data, information and analysis on the global anesthesia and respiratory devices market. The report p more

Websites Pulmonary Disease